Lifeonics Limited, a developer of smart, in-situ analytical devices is pleased to announce the signing of a distribution agreement with DI Biotech, the leading supplier to the Korean life-science market.
DI Biotech will market and support the SMOD™ proprietary technology to the Korean academic, pharmaceutical and biotech markets. SMOD is a miniaturized device for real time, non intervention monitoring of cell culture fermentation ideally suited for laboratories growing cells in flasks.
Clive Seymour, CEO of Lifeonics comments, “We are very happy to have DI Biotech representing our products in the Korean market. DI Biotech is an organization with longstanding presence, experience and a respected position as a leading supplier of high-tech tools to the life science and biotech markets. To launch SMOD in Korea in partnership with DI Biotech gives us confidence that our revolutionary technology will achieve a rapid acceptance in this key Asian market”
S. E. Kim, CEO and President at DI Biotech comments, “We believe that this innovative technology will rapidly replace the current time consuming and less than optimal method for crucial cell culture monitoring process in laboratories throughout Korea. Our market reach across the life science, pharmaceutical and biotech fields will, we believe, result in SMOD becoming the new norm in laboratories for this application